Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

103.29 +3.02 (+3.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Moderna's Shares Could Take Off if These 2 Things Happen
Moderna stock soared early in the pandemic. 
Via The Motley Fool
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
The COVID-19 vaccine put Moderna on the map, but its pipeline is going to be what keeps it there. 
Via The Motley Fool
Exposures COVID-19
Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
Via ACCESSWIRE
Why Pfizer and BioNTech Stocks Zoomed Higher Today
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle. 
Via The Motley Fool
Exposures COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
Looking Into Moderna's Recent Short Interest
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
If I Could Only Buy 3 Stocks in 2023, I'd Pick These
These stocks have what it takes to grow in leaps and bounds. 
Via The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria.  More than a million people worldwide succumb to infections caused... 
Via Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in... 
Via Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer
The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight. 
Via InvestorPlace
Don’t Miss the Boom: 3 Healthcare Stocks Set to Explode Higher
These companies can be expected to outperform as healthcare stocks come back into the good graces of investors. 
Via InvestorPlace
Moderna Talks Offer Hope for Enhanced COVID-19 Vaccine Availability In Europe
European countries are actively negotiating a fresh COVID-19 vaccine procurement agreement with Moderna Inc (NASDAQ: MRNA) as concerns mount within EU health authorities regarding a surge in... 
Via Benzinga
Exposures COVID-19
Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.
These three healthcare stocks to sell are waving red flags at investors who should pay attention or suffer the consequences. 
Via InvestorPlace
Moderna Is Expecting Massive Growth Over the Next Decade. Is the Stock a No-Brainer Buy?
The stock has been struggling this year, but could things soon be getting brighter for Moderna? 
Via The Motley Fool
Does This Message From Moderna Mean Bad News for Novavax?
So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market. 
Via The Motley Fool
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
I favor holding onto these players for the long term to truly benefit from their earnings potential. 
Via The Motley Fool
Price Targets
Along with giving buy, sell, or hold ratings on the stocks they cover, Wall Street analysts also provide investors with a price target. 
Via Talk Markets
Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
As the U.S. 
Via Benzinga
Exposures COVID-19
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of. 
Via InvestorPlace
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
All three companies should benefit from increased COVID-19 booster sales. 
Via The Motley Fool
Exposures COVID-19
Beware! 3 Value Stocks Waving Massive Red Flags Right Now.
Traps are omnipresent today. Don't fall for low ratios and cheap stats, but look for underlying potential. Heed these value stocks to avoid. 
Via InvestorPlace
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These stocks could take off in the years to come. 
Via The Motley Fool
Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now.
A range of worries are pulling these Nasdaq stocks to sell lower and clouding the outlook for their share prices. 
Via InvestorPlace
3 Stocks to Avoid Like the Plague Right Now: MRNA, GPS, PTON
The good economic times of the past few years appear to be ending. As such, it's time to exit these three stocks to avoid. 
Via InvestorPlace
Amazon, Moderna And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly higher on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
2 Stocks That Sank Hard on Monday
Investors were generally in wait-and-see mode, but not with certain individual stocks. 
Via The Motley Fool
Why Moderna Stock Is Sinking Today
Moderna, Inc. (NASDAQ: MRNA) shares are trading lower Monday alongside other vaccine stocks amid a selloff after the sector gained amid ri 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.